MetaVia begins higher-dose phase 1 trial of obesity drug DA-1726

April 10, 2026 8:30 AM

MetaVia Inc. (NASDAQ: MTVA) announced it has dosed the first patient in Part 3 of its Phase 1 clinical trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found